This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.


Covid-19 Vaccine Equity Project – Kenya

As the COVID-19 pandemic continues to gain momentum globally, the need to vaccinate a majority of the population is becoming critical. Already, millions of doses of the COVID-19 vaccine have been administered across Kenya, yet many people remain hesitant to take the vaccine, slowing down the global vaccine rollout.

PATH's Living Labs, Amref, Dalberg, and JSI, are a group of designers, behavioural scientists, immunisation professionals, and health service providers/implementers. In partnership, we conducted research to understand the perceptions and motivations of Kenyans with regards to the COVID-19 vaccine to help boost its uptake amongst eligible populations through targeted campaigns.

Publication date: November 2021

Available materials

    1. Covid-19 Vaccine Equity Project – Kenya 507.6 KB PDF
    2. Addressing vaccine hesitancy in Kenya 6.1 MB PDF